New
HealthMore in Health→
Study links chemo resistance in ovarian cancer to immune response
Key Takeaways
- A Wistar Institute study links ovarian cancer chemoresistance to chemotherapy-triggered inflammation.
- Researchers say immune cells recruited into the tumor microenvironment can protect cancer from later treatment.
- The pathway may be targetable with drugs already used clinically for other diseases.
DE
DT Editorial Team··via medicalxpress.com